SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(PAKKANEN A)
 

Sökning: WFRF:(PAKKANEN A) > (2015-2019) > Specific and Cross-...

Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine

Pakkanen, S. H. (författare)
Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.
Kantele, J. M. (författare)
Univ Turku, Dept Publ Hlth, Occupat Hlth & Environm Med, Turku, Finland.
Rombo, L. (författare)
Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.
visa fler...
Kantele, A. (författare)
Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.;Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.;Univ Helsinki, Dept Med, Clinicum, Helsinki, Finland.;Univ Helsinki, Div Infect Dis, Inflammat Ctr, Helsinki, Finland.;Helsinki Univ Hosp, Helsinki, Finland.;Med Ctr Aava, Aava Travel Clin, Helsinki, Finland.
visa färre...
Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland Univ Turku, Dept Publ Hlth, Occupat Hlth & Environm Med, Turku, Finland. (creator_code:org_t)
2017-09-27
2017
Engelska.
Ingår i: Scandinavian Journal of Immunology. - : WILEY. - 0300-9475 .- 1365-3083. ; 86:4, s. 207-215
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Secondary immunization with polysaccharide vaccines may imply a risk of hyporesponsiveness. Despite the wide use of typhoid Vi capsular polysaccharide vaccine, its potential tendency to hyporesponsiveness has been inadequately addressed. While previous studies have explored serum antibody responses, we applied a more sensitive approach, a single-cell assay for circulating plasmablasts, to compare primary and secondary responses. Twelve subjects received primary and booster doses of the Vi vaccine (Typherix (R)) at 30-to 37-month intervals. Plasmablasts specific to the Vi or typhoidal O antigens or cross-reactive with paratyphoid and non-typhoidal Salmonella strains were identified as antibodysecreting cells (ASC) with ELISPOT. Before vaccinations, none had plasmablasts specific to the antigens tested. Twelve of 12 subjects showed a Vi-specific response after primary, but only eight of 12 after booster vaccination. All responded to typhoidal O-9,12 antigen after both immunizations. The geometric mean of plasmablasts specific to the Vi antigen was 59 (95% CI 24-119) and 1 (0-54) IgA + IgG + IgM-ASC/10(6) peripheral blood mononuclear cell (PBMC) after primary and booster immunizations, respectively, and 20 (9-49) and 56 (29-103) to the O-9,12 antigen. We detected 1 (0-28) and 17 (6-36) ASC/10(6) PBMC cross-reactive with Salmonella Paratyphi A; 3 (0-30) and 22 (8-48) with S. Paratyphi B; 3 (0-29) and 18 (7-47) with S. Paratyphi C; 19 (10-34) and 51 (26-94) with Salmonella Enteritidis; and 1 (0-35) and 23 (9-52) with Salmonella Typhimurium, respectively. One-third of the vaccinees, although responding to the O-9,12 antigen, failed to respond to the Vi antigen after booster immunization, suggesting hyporesponsiveness in part of the vaccinees. The findings warrant further investigation.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy